메뉴 건너뛰기




Volumn 25, Issue 23, 2007, Pages 3552-

Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists [4]

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; PACLITAXEL;

EID: 34548173956     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.2960     Document Type: Letter
Times cited : (2)

References (4)
  • 1
    • 34247094747 scopus 로고    scopus 로고
    • Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?
    • Silber JH, Rosenbaum PR, Polsky D, et al: Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy? J Clin Oncol 25:1169-1175, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 1169-1175
    • Silber, J.H.1    Rosenbaum, P.R.2    Polsky, D.3
  • 2
    • 34247175381 scopus 로고    scopus 로고
    • Gynecologic oncology or medical oncology: What's in a name?
    • Cannistra SA: Gynecologic oncology or medical oncology: What's in a name? J Clin Oncol 25:1157-1159, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 1157-1159
    • Cannistra, S.A.1
  • 4
    • 0034268483 scopus 로고    scopus 로고
    • Guidelines for referral to a gynecologic oncologist: Rationale and benefits
    • Society of Gynecologic Oncologists
    • Society of Gynecologic Oncologists: Guidelines for referral to a gynecologic oncologist: Rationale and benefits. Gynecol Oncol 78:S1-S13, 2000. http://www.sgo.org/images/pdfs/publications/referralguide.pdf
    • (2000) Gynecol Oncol , vol.78


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.